The Latest

  • A portrait of Rick Baehner
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott launches MRD test with improved cancer detection tech

    Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

  • The Stryker logo is displayed on an office building with hills in the background.
    Image attribution tooltip
    JHVEPhoto via Getty Images
    Image attribution tooltip

    Stryker completes ZuriMED takeover

    The deal expands Stryker’s portfolio of fast-growing sports medicine and shoulder care devices.

    M&A
  • A person sitting on a white couch speaks and looks to the side.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip
    The MedTech Conference 2026

    Overheard in Boston: Medtech CEOs talk rising costs, turbulent markets, cyberattacks

    At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, inflation and new technologies.

  • A Labcorp sign in front of an office building and palm trees.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Labcorp inks Millennium Health buyout to add drug testing services

    The proposed acquisition of the specialty laboratory is the third Labcorp buyout announced in eight days.

    M&A
  • A person wearing goggles and a mask taps a tablet screen attached to a square machine.
    Image attribution tooltip
    Courtesy of Qiagen
    Image attribution tooltip

    Qiagen agrees to private equity takeover

    EQT Private Equity has agreed to pay about $12.1 billion, including debt, for the diagnostics company, which has long been the subject of takeover speculation.

    M&A
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards wins FDA approval for tricuspid valve repair device

    Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” analysts said.

  • An overhead shot of a conference hall shows many booths with people gathering.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip

    Medtech leaders discuss AI, cybersecurity and M&A at AdvaMed’s The MedTech Conference

    More than 4,000 people across the medtech sector met in Boston for one of the industry’s biggest events of the year. Catch up on all the conference news in MedTech Dive’s roundup.

  • A sign for the Food And Drug Administration is seen
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Developers, not doctors, should be held accountable for generative AI medical devices, providers say

    Provider groups are lobbying the Food and Drug Administration to make tech companies responsible for the safety and performance of generative AI-backed medical devices, arguing the tools’ makers are best equipped to evaluate them.

    AI
  • An image of a horizontal building with a driveway.
    Image attribution tooltip
    Retrieved from Olympus on October 22, 2026
    Image attribution tooltip

    FDA flags more Olympus safety problems in import block and warning letter

    The FDA import alert broadens the scope of a 2025 import action covering dozens of endoscopes and comes two weeks after a new warning letter identified numerous quality system violations.

    FDA
  • A picture of San Francisco's Coit Tower and downtown at dawn.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Top medtech conferences in 2027

    From AdvaMed’s meeting in San Francisco to a robotics conference in Rome, next year’s calendar is already filled with medtech events to attend.

  • Quest Diagnostics building
    Image attribution tooltip
    Courtesy of Quest Diagnostics
    Image attribution tooltip

    Quest Diagnostics hit by cyberattack

    The testing company believes an unauthorized third party accessed patient records.

  • A Labcorp sign in front of an office building and palm trees.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Labcorp to buy Myriad’s prenatal health testing unit for $210M

    Buying the Myriad assets will expand Labcorp’s portfolio of specialty tests for women’s health.

    M&A
  • A person speaks while standing in front of a podium.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip
    The MedTech Conference 2026

    CDRH on hiring spree after significant staff losses, director says

    Dr. Michelle Tarver said the FDA’s device center is filling positions after losing large numbers of clinical reviewers, as well as AI and digital health experts.

    FDA
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott plans to spin out its nutrition business

    Abbott, which also cut its 2026 sales growth guidance, said company sales will total $42 billion following the separation.

    M&A
  • A modern office building with large reflective glass windows is shown behind a wide driveway and landscaped entrance. In the foreground, a white and orange monument sign reads "Intuitive Surgical" with the number "1020" vertically on the side.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Intuitive’s US da Vinci procedure growth slows again

    Facing continued softness, Intuitive outlined opportunities to increase use of its robots in benign general surgeries.

  • A person wearing a suit sits in a white chair.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip
    The MedTech Conference 2026

    Expect more tuck-in M&A, portfolio pruning in medtech, execs say

    As medical device makers face “finite” capital, portfolio reshaping will likely remain a focus in the sector.

    M&A
  • Three people sit on a couch. The person on a left, in a yellow dress, speaks.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip
    The MedTech Conference 2026

    Gen AI policy is a White House priority, CDRH digital health leader says

    Rick Abramson, director of the FDA’s Digital Health Center of Excellence, said to expect draft guidance in the coming months.

    FDA
  • The exterior of a convention center at sunrise is viewed from across the street.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip
    The MedTech Conference 2026

    Cybersecurity in focus for top medtech lobby

    ResMed CEO Mick Farrell, chair of AdvaMed’s board, said the group plans to come up with standards around privacy, cybersecurity and interoperability.

  • A worker operates a forklift full of boxes.
    Image attribution tooltip
    Courtesy of Vantive
    Image attribution tooltip
    The MedTech Conference 2026

    Medtech execs share secrets to building resilient supply chains

    At AdvaMed’s The MedTech Conference, company executives said they’re bracing for disruption by investing in inventory, scenario planning and their relationships with chip suppliers.

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for Vitalis portfolio of cardiac pacemakers

    The CE mark clears Medtronic to sell conduction system pacing therapy devices in Europe.

  • A worker in white coat and purple gloves scans a Galleri test box.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    5 doctors weigh in on the promise, limitations of Grail’s multicancer test

    As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer experts what encourages and concerns them most about Galleri.

  • A white, rounded device is open showing clear tubing inside.
    Image attribution tooltip
    Permission granted by Sequel Medtech
    Image attribution tooltip

    FDA clears Sequel’s insulin delivery system in Type 2 diabetes

    With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.

  • A modern architectural design building featuring a red-brick façade with large glass windows displays a prominent sign of the Food and Drug Administration.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Edwards recall of Sapien mitral delivery systems tied to 1 death

    Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three reports of balloons bursting when inflated during the procedure.